Patents by Inventor Kui Lin

Kui Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240354698
    Abstract: A tote processing method includes: obtaining at least one to-be-processed order corresponding to a target workstation; determining target totes and a carrying sequence of each of the target totes according to an order demand of the at least one to-be-processed order and a processing sequence corresponding to each to-be-processed order; and generating a carrying instruction according to the target totes and the carrying sequence of each of the target totes, to control, based on the carrying instruction, a robot to carry each of the target totes, where the order demand of the to-be-processed order includes a type and a quantity of target items corresponding to the to-be-processed order, and the processing sequence of the to-be-processed order is a processing sequence of each of the target items in the order demand of the to-be-processed order.
    Type: Application
    Filed: June 27, 2024
    Publication date: October 24, 2024
    Inventors: Han LIN, Runfang YU, Kui WANG
  • Patent number: 12112744
    Abstract: The disclosure provides a multimodal speech recognition method and system, and a computer-readable storage medium. The method includes calculating a first logarithmic mel-frequency spectral coefficient and a second logarithmic mel-frequency spectral coefficient when a target millimeter-wave signal and a target audio signal both contain speech information corresponding to a target user; inputting the first and the second logarithmic mel-frequency spectral coefficient into a fusion network to determine a target fusion feature, where the fusion network includes at least a calibration module and a mapping module, the calibration module is configured to perform mutual feature calibration on the target audio/millimeter-wave signals, and the mapping module is configured to fuse a calibrated millimeter-wave feature and a calibrated audio feature; and inputting the target fusion feature into a semantic feature network to determine a speech recognition result corresponding to the target user.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: October 8, 2024
    Assignee: Zhejiang University
    Inventors: Feng Lin, Tiantian Liu, Ming Gao, Chao Wang, Zhongjie Ba, Jinsong Han, Wenyao Xu, Kui Ren
  • Patent number: 12083129
    Abstract: Provided herein are combination therapies comprising an ATP competitive AKT inhibitor, fulvestrant, and CDK4/6 inhibitor for use in treating hormone receptor positive and HER2 negative locally advanced unresectable or metastatic breast cancer.
    Type: Grant
    Filed: January 25, 2023
    Date of Patent: September 10, 2024
    Assignee: Genentech, Inc.
    Inventor: Kui Lin
  • Publication number: 20240290629
    Abstract: A method for CMP includes following operations. A first metal layer and a second metal layer are formed in a dielectric structure. The second metal layer is formed over a portion of the first metal layer. A first composition is provided to remove a portion of the first metal layer. A second composition is provided to form a protecting layer over the second metal layer. The protecting layer is removed to expose the second metal layer. A CMP operation is performed to remove a portion of the first metal layer, a portion of the second metal layer and a portion of the dielectric structure.
    Type: Application
    Filed: April 29, 2024
    Publication date: August 29, 2024
    Inventors: JI CUI, FU-MING HUANG, TING-KUI CHANG, TANG-KUEI CHANG, CHUN-CHIEH LIN, WEI-WEI LIANG, LIANG-GUANG CHEN, KEI-WEI CHEN, HUNG YEN, TING-HSUN CHANG, CHI-HSIANG SHEN, LI-CHIEH WU, CHI-JEN LIU
  • Publication number: 20230381156
    Abstract: Provided herein are combination therapies comprising GDC-9545 and ipatasertib for treating locally advanced breast cancer or metastatic breast cancer.
    Type: Application
    Filed: August 15, 2023
    Publication date: November 30, 2023
    Applicant: Genentech, Inc.
    Inventors: Ciara METCALFE, Kui LIN, Marc Antoine HAFNER
  • Publication number: 20230330106
    Abstract: Provided herein are combination therapies comprising an ATP competitive AKT inhibitor, fulvestrant, and CDK4/6 inhibitor for use in treating hormone receptor positive and HER2 negative locally advanced unresectable or metastatic breast cancer.
    Type: Application
    Filed: January 25, 2023
    Publication date: October 19, 2023
    Inventor: Kui Lin
  • Patent number: 11576919
    Abstract: Provided herein are combination therapies comprising an ATP competitive AKT inhibitor, fulvestrant, and CDK4/6 inhibitor for use in treating hormone receptor positive and HER2 negative locally advanced unresectable or metastatic breast cancer.
    Type: Grant
    Filed: August 10, 2020
    Date of Patent: February 14, 2023
    Assignee: Genentech, Inc.
    Inventor: Kui Lin
  • Patent number: 11169710
    Abstract: A media management system including an application layer, a system layer, and a solid state drive (SSD) storage layer. The application layer includes a media data analytics application configured to assign a classification code to a data file. The system layer is in communication with the application layer. The system layer includes a file system configured to issue a write command to a SSD controller. The write command includes the classification code of the data file. The SSD storage layer includes the SSD controller and erasable blocks. The SSD controller is configured to write the data file to one of the erasable blocks based on the classification code of the data file in the write command. In an embodiment, the SSD controller is configured to write the data file to one of the erasable blocks storing other data files also having the classification code.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: November 9, 2021
    Assignee: Futurewei Technologies, Inc.
    Inventors: Yiren Huang, Yong Wang, Kui Lin
  • Publication number: 20210046086
    Abstract: Provided herein are combination therapies comprising an ATP competitive AKT inhibitor, fulvestrant, and CDK4/6 inhibitor for use in treating hormone receptor positive and HER2 negative locally advanced unresectable or metastatic breast cancer.
    Type: Application
    Filed: August 10, 2020
    Publication date: February 18, 2021
    Applicant: Genentech, Inc.
    Inventor: KUI LIN
  • Publication number: 20200249211
    Abstract: Disclosed is a method for quantifying the taste of wine, comprising the following steps: S1: selecting a sample of the wine; S2: selecting the alcoholic strength, total acidity, total sugar, glycerol, dimethyl butanol, esters and resveratrol as the quantitative indexes of the taste of the wine; S3: detecting the quantitative indexes selected in S2; S4: standardizing the detection results obtained in S3 by using a Max?Min standardized method, and classifying and assigning values to the standardized data by grade, with the value assignment results being associated with a good or a bad taste; and S5: creating a chart according to the standardized detection results from S4, and describing the taste of the wine according to the chart.
    Type: Application
    Filed: April 20, 2020
    Publication date: August 6, 2020
    Inventors: Hao Wu, Yan Kui Lin, Dao Jian Yu, Li Ya Ge, Jie Luo, Yue Mei Li
  • Patent number: 10612100
    Abstract: Methods for identifying or diagnosing AKT inhibitor resistant cancers and methods an compositions for treating.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: April 7, 2020
    Assignee: Genentech, Inc.
    Inventor: Kui Lin
  • Publication number: 20190138221
    Abstract: A media management system including an application layer, a system layer, and a solid state drive (SSD) storage layer. The application layer includes a media data analytics application configured to assign a classification code to a data file. The system layer is in communication with the application layer. The system layer includes a file system configured to issue a write command to a SSD controller. The write command includes the classification code of the data file. The SSD storage layer includes the SSD controller and erasable blocks. The SSD controller is configured to write the data file to one of the erasable blocks based on the classification code of the data file in the write command. In an embodiment, the SSD controller is configured to write the data file to one of the erasable blocks storing other data files also having the classification code.
    Type: Application
    Filed: September 27, 2018
    Publication date: May 9, 2019
    Inventors: Yiren Huang, Yong Wang, Kui Lin
  • Publication number: 20190034684
    Abstract: The present invention relates to a method and system for quantitative defacing of a QR Code. Defacing of the method includes data and error correction code word defacing, boundary defacing, position detection pattern defacing, correction pattern defacing, positioning pattern defacing, version information defacing, and format information defacing. Quantitative defacing varies with the defacing patterns and positions of a barcode. The defacing degree of the QR Code is not greater than the capability of the barcode for correcting error codes. The number of coding characters of the QR Code is required to be equal to the character number of a data code word which is specified by a current barcode version and correction grade, and the situation of adding filling characters does not exist. Defacing of the data and error correction code words does not include defacing of remaining bits. Defacing patterns include pre-stage printing defacing and rear-stage actual defacing.
    Type: Application
    Filed: August 12, 2016
    Publication date: January 31, 2019
    Applicant: FUJIAN LANDI COMMERCIAL EQUIPMENT CO., LTD
    Inventors: Weijian XIAO, Kui LIN
  • Publication number: 20180360835
    Abstract: Provided herein are biomarkers, and combinations of biomarkers, for predicting sensitivity to cancer treatments.
    Type: Application
    Filed: September 5, 2018
    Publication date: December 20, 2018
    Applicant: Genentech, Inc.
    Inventors: Kui Lin, Elizabeth Punnoose, Somasekar Seshagiri
  • Publication number: 20180327860
    Abstract: Methods for identifying or diagnosing AKT inhibitor resistant cancers and methods an compositions for treating.
    Type: Application
    Filed: May 8, 2018
    Publication date: November 15, 2018
    Applicant: GENENTECH, INC.
    Inventor: Kui Lin
  • Patent number: 10104193
    Abstract: In one embodiment, a method of serving media includes receiving a request to serve a cacheable media content to a user equipment at a second media server deployed in a second layer2 access network. The request is received around when the user equipment is handed-off from a first layer2 node in a first layer2 access network to a second layer2 node in the second layer2 access network and when a streaming session of the cacheable media content to the user equipment from a first media server is terminated. The method further includes determining if the cacheable media content is stored in a cache of the second media server, and serving the cacheable media content from the cache of the second media server to the user equipment if the media content is stored in the cache of the second media server.
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: October 16, 2018
    Assignee: Futurewei Technologies, Inc.
    Inventors: Sanqi Li, Tao Qian, Houxiao Han, Hongbo Tian, Kui Lin
  • Patent number: 10092567
    Abstract: The invention provides combinations comprising a) compound of formula I: or a pharmaceutically acceptable salt thereof wherein R1, R2, R5, R10, and A have any of the values defined in the specification; and b) one or more agents selected from 5-FU, a platinum agent, leucovorin, irinotecan, docetaxel, doxorubicin, gemcitabine, SN-38, capecitabine, temozolomide, paclitaxel, bevacizumab, pertuzumab, tamoxifen, rapamycin and lapatinib. The combinations are particularly useful for treating hyperproliferative disorders, such as cancer.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: October 9, 2018
    Assignee: GENENTECH, INC.
    Inventors: Kui Lin, Michelle Nannini, Elizabeth Punnoose, Deepak Sampath, Jeffrey Wallin, Premal Patel
  • Patent number: 10089017
    Abstract: A media management system including an application layer, a system layer, and a solid state drive (SSD) storage layer. The application layer includes a media data analytics application configured to assign a classification code to a data file. The system layer is in communication with the application layer. The system layer includes a file system configured to issue a write command to a SSD controller. The write command includes the classification code of the data file. The SSD storage layer includes the SSD controller and erasable blocks. The SSD controller is configured to write the data file to one of the erasable blocks based on the classification code of the data file in the write command. In an embodiment, the SSD controller is configured to write the data file to one of the erasable blocks storing other data files also having the classification code.
    Type: Grant
    Filed: May 22, 2012
    Date of Patent: October 2, 2018
    Assignee: FUTUREWEI TECHNOLOGIES, INC.
    Inventors: Yiren Huang, Yong Wang, Kui Lin
  • Patent number: 9994913
    Abstract: Methods for identifying or diagnosing AKT inhibitor resistant cancers and methods an compositions for treating.
    Type: Grant
    Filed: August 21, 2015
    Date of Patent: June 12, 2018
    Assignee: Genentech, Inc.
    Inventor: Kui Lin
  • Publication number: 20170237798
    Abstract: In one embodiment, a method of serving media includes receiving a delivery log of traffic use after every first time interval for an user equipment. The user equipment is part of a hot billing class of users. The traffic use comprises data usage by the user equipment during communication with a media server in a layer2 access network. A user traffic information computed from the delivery log is transmitted to a billing center. A account status information is received from the billing center. The account status information is received if the user equipment exceeds a user account metric. A session termination information based on the account status information is transmitted.
    Type: Application
    Filed: March 3, 2017
    Publication date: August 17, 2017
    Inventors: Sanqi Li, Tao Qian, Houxiao Han, Hongbo Tian, Kui Lin